Korean J Gastroenterol.  2010 Nov;56(5):336-337. 10.4166/kjg.2010.56.5.336.

(Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor alpha Inhibitors in Murine Gastrointestinal Stromal Tumors. Gastroenterology 2010;139:942-952)

Abstract

No abstract available.


Reference

1. Bardsley MR, Horvá th VJ, Asuzu DT, et al. Kit low stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors. Gastroenterology. 2010; 139:942–952.
2. Stewart DR, Corless CL, Rubin BP, et al. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet. 2007; 44:e61.
Article
3. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279:577–580.
4. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007; 369:1731–1741.
Article
5. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009; 296:G1370–1381.
Article
6. Lopes LF, West RB, Bacchi LM, van de Rijn M, Bacchi CE. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Appl Im-munohistochem Mol Morphol. 2010; 18:333–337.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr